Results 171 to 180 of about 52,325 (288)
Estudio clínico de herpes zóster en niños
Víctor Fernando Muñoz Estrada +2 more
openalex +1 more source
Efficacy of upadacitinib induction for pediatric inflammatory bowel disease
Abstract Objectives Upadacitinib, a second‐generation Janus kinase (JAK) inhibitor, is approved for moderate to severe Crohn's disease (CD) and ulcerative colitis (UC) in adults. Its efficacy in pediatric patients remains unclear, though early reports suggest benefits in refractory inflammatory bowel disease (IBD).
Evan Greenhall +5 more
wiley +1 more source
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin +8 more
wiley +1 more source
Herpes Zoster and Frailty in Older Adults: a Systematic Review. [PDF]
D'Elia MPB, Andrew MK, Pott H.
europepmc +1 more source
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra +51 more
wiley +1 more source
Sacral Herpes Zoster Mimicking Pressure Ulcers and Causing Elsberg Syndrome. [PDF]
Yamada J +5 more
europepmc +1 more source

